BAMCO Inc
BEAM icon

BAMCO Inc’s Beam Therapeutics BEAM Stock Holding History

BAMCO Inc’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,000
Closed -$991K – 331
2024
Q1 		$991K Buy
+30,000
New +$935K ﹤0.01% 306
2022
Q1 		– Sell
-15,717
Closed -$1.25M – 394
2021
Q4 		$1.25M Buy
15,717
+2,700
+21% +$231K ﹤0.01% 367
2021
Q3 		$1.13M Sell
13,017
-4,800
-27% -$482K ﹤0.01% 367
2021
Q2 		$2.29M Sell
17,817
-80,200
-82% -$6.39M 0.01% 346
2021
Q1 		$7.84M Buy
+98,017
New +$9.32M 0.02% 302

Other funds holding BEAM

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

BAMCO Inc's BEAM Position: Q2 2024 in Review

BAMCO Inc sold out of Beam Therapeutics (BEAM) in Q2 2024, closing a stake of 30,000 shares — an estimated $991K sold.

BAMCO Inc first reported a position in BEAM in Q1 2021 and held it in 5 quarters. The position peaked at $7.84M in Q1 2021. 214 funds tracked by Wall St. Rank hold BEAM as of Q2 2024.

  • BAMCO Inc reported no remaining Beam Therapeutics position as of Q2 2024 after selling out during the quarter.
  • BAMCO Inc sold 30,000 Beam Therapeutics shares in Q2 2024, an estimated $991K.
  • BAMCO Inc first reported a position in Beam Therapeutics in Q1 2021 and held it in 5 quarters.
  • BAMCO Inc's Beam Therapeutics position peaked at $7.84M in Q1 2021.
  • 214 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2024.

Based on BAMCO Inc's 13F filing for Q2 2024, filed 14 Aug 2024.